Trial Profile
Clinical Trials Insight: 700009417
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2010
Price :
$35
*
At a glance
- Drugs VP 025 (Primary)
- Indications Alzheimer's disease; Amyotrophic lateral sclerosis; Inflammation; Neurological disorders; Parkinson's disease
- Focus Adverse reactions
- Sponsors Intellipharmaceutics International
- 29 Nov 2005 New trial record.